D-1389-2019 Class II Terminated
FDA drug recall D-1389-2019 was initiated by Sun Pharmaceutical Industries, Inc. on Jun 5, 2019 and is designated Class II. Reason for recall: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit The recall status is terminated (terminated Jan 8, 2021). Affected quantity: 14,399 30-count units.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2019
- Initiation Date
- Jun 5, 2019
- Termination Date
- Jan 8, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,399 30-count units
Product description
Wal-Fex D Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg/ Extended-Release Tablets, USP, Allergy & Congestion, 30-count box. Distributed by: Walgreen Co. 200 Wilmore Rd. Deerfield, IL 40015. Made in India. UPC 3 11917 19454 7
Reason for recall
Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Distribution pattern
Nationwide in the USA
Code information
Lot: GKS1014, EXP 09/2019; GKT0484A, EXP 04/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1389-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026